Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice

Background: SARS-CoV-2 has caused a global pandemic, infecting millions of people. A safe, effective vaccine is urgently needed and remains a global health priority. Subunit vaccines are used successfully against other viruses when administered in the presence of an effective adjuvant. Methods: We e...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Katharina Wørzner, Daniel J. Sheward, Signe Tandrup Schmidt, Leo Hanke, Julie Zimmermann, Gerald McInerney, Gunilla B. Karlsson Hedestam, Ben Murrell, Dennis Christensen, Gabriel Kristian Pedersen
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2021-01-01
Saila:	EBioMedicine
Gaiak:	SARS-CoV-2 Alum Subunit vaccine CAF®01 MF59TM Squalene emulsion
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2352396420305739
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!